BRAF and cutaneous melanoma: The current guidelines for the treatment of cutaneous melanoma include [103]: (A) immunotherapy drugs (immune checkpoint inhibitors) such as pembrolizumab (Keytruda) or nivolumab (Opdivo) as the first drugs tried, especially in tumors without BRAF gene mutation.